Millennium: The Takeda Oncology Company
United States
281 articles about Millennium: The Takeda Oncology Company
-
Weber Shandwick Worldwide Release: Biotechnology And Pharmaceutical Executives From New England's Top Companies To Attend The Second Annual Convergence - The Life Sciences Leaders Forum
4/12/2005
-
The Week In Review: From Optimism To Pessimism In Three Short Weeks
3/27/2005
-
Universal Assay Kit For Kinase And Phosphatase Development From QTL Biosystems
3/18/2005
-
Biotech Bargain Hunting
3/14/2005
-
Millennium Pharmaceuticals, Inc. (MLNM) Achieves Milestone Payments Of Approximately $40 Million
3/8/2005
-
Biotech/Pharma Earnings Today
1/27/2005
-
Biotech 2005: New Drugs Hold The Key
12/29/2004
-
R&D Directions Release: Leading Heads From Pharma, Biotech And Academia Discuss Pipelines At Drug Development Summit 2005
12/14/2004
-
Millennium Pharmaceuticals, Inc. Release: VELCADE(R) (Bortezomib) For Injection Studies Results Indicate Potential Utility Across The Multiple Myeloma Treatment Paradigm
12/7/2004
-
Millennium Pharmaceuticals, Inc. Release: VELCADE(R) (bortezomib) For Injection Continues To Provide Responses In Several Subtypes Of Non-Hodgkin's Lymphoma
12/7/2004
-
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts)
9/27/2004
-
QRxPharma In Hunt For Drugs In Reptiles' Venom
9/20/2004
-
Biotechs Drop Genomics Moniker
8/10/2004
-
Playing The High-Stakes Biotech Game
7/8/2004
-
Research Back In Fashion
6/21/2004
-
Biotech Stocks Rise On Cancer Drug Data
6/7/2004
-
Big Pharma Could Hog Biotech's Spotlight
6/3/2004
-
Millennium Pharmaceuticals (MLNM) Announces VELCADE(R) (bortezomib) For Injection Has Significantly Extended Survival In Phase III (APEX) Trial Of Patients With Relapsed Multiple Myeloma; Stock Jumps
5/18/2004
-
New Story
3/19/2004
-
Top 2003 Stories From The BioSpace NewsBeat
12/31/2003